Electromedical Technologies, Inc.
EMED
$0.0002
$0.000.00%
| Weiss Ratings | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.16 | |||
| Price History | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -50.00% | |||
| 90-Day Total Return | -60.00% | |||
| Year to Date Total Return | -50.00% | |||
| 1-Year Total Return | -71.43% | |||
| 2-Year Total Return | -96.36% | |||
| 3-Year Total Return | -99.30% | |||
| 5-Year Total Return | -99.95% | |||
| 52-Week High % Change | -88.89% | |||
| 52-Week Low % Change | 100.00% | |||
| Price | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jan 21, 2025 | |||
| 52-Week High Price (Date) | Aug 13, 2024 | |||
| Valuation | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 186.01K | |||
| Enterprise Value | 2.58M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -75.17% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.15 | |||
| Price/Book (Q) | -0.03 | |||
| Enterprise Value/Revenue (TTM) | 2.79 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -2.56 | |||
| Enterprise Value/EBIT | -2.55 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 681.00M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 888 880 7888 | |||
| Address | 16413 North 91st Street Scottsdale, AZ 85260 | |||
| Website | electromedtech.com | |||
| Country | United States | |||
| Year Founded | 2002 | |||
| Profitability | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -109.63% | |||
| Profit Margin | -182.05% | |||
| Management Effectiveness | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -88.83% | |||
| Return on Equity | -- | |||
| Income Statement | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 921.90K | |||
| Total Revenue (TTM) | 921.90K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | 692.20K | |||
| EBITDA (TTM) | -1.01M | |||
| EBIT (TTM) | -1.01M | |||
| Net Income (TTM) | -1.68M | |||
| Net Income Avl. to Common (TTM) | -1.68M | |||
| Total Revenue Growth (Q YOY) | -86.87% | |||
| Earnings Growth (Q YOY) | -92.35% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | -37.50% | |||
| Balance Sheet | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 34.80K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 305.40K | |||
| Total Preferred Equity (Q) | 0.77 | |||
| Total Equity (Q) | -4.00M | |||
| Current Ratio (Q) | 0.070 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 568.80K | |||
| Total Current Liabilities (Q) | 4.36M | |||
| Total Debt (Q) | 1.66M | |||
| Total Liabilities (Q) | 4.57M | |||
| Total Common Equity (Q) | -4.77M | |||
| Cash Flow | EMED - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 0.00 | |||
| Cash from Financing (TTM) | 27.60K | |||
| Net Change in Cash (TTM) | -103.70K | |||
| Levered Free Cash Flow (TTM) | 679.90K | |||
| Cash from Operations (TTM) | -131.20K | |||
